​

Xencor (XNCR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

XNCR Stock Forecast

Xencor (XNCR) stock forecast, based on 28 Wall Street analysts, predicts a 12-month average price target of $34.40, with a high of $46.00 and a low of $20.00. This represents a 37.93% increase from the last price of $24.94.

$15 $22 $29 $36 $43 $50 High: $46 Avg: $34.4 Low: $20 Last Closed Price: $24.94

XNCR Stock Rating

Xencor stock's rating consensus is Buy, based on 28 Wall Street analysts. The breakdown includes 1 Strong Buy (3.57%), 24 Buy (85.71%), 2 Hold (7.14%), 1 Sell (3.57%), and 0 Strong Sell (0.00%).

Buy
Total 28 1 2 24 1 Strong Sell Sell Hold Buy Strong Buy

XNCR Price Target Upside V Benchmarks

TypeNameUpside
StockXencor37.93%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts2511
Avg Price Target$40.50$34.40$28.73
Last Closing Price$24.94$24.94$24.94
Upside/Downside62.39%37.93%15.20%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26392--14
Aug, 26392--14
Jul, 26392--14
Jun, 26392--14
May, 26392--14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 11, 2026Barclays$35.00$24.2644.27%40.34%
Sep 01, 2026Raymond James$46.00$27.2768.68%84.44%
Aug 06, 2026Steve SeedhouseCantor Fitzgerald$44.00$20.50114.63%76.42%
Aug 06, 2026RBC Capital$20.00$19.840.81%-19.81%
Jul 07, 2026Truist Financial$27.00$15.1378.45%8.26%
Dec 17, 2025Barclays$26.00$16.5557.10%4.25%
Nov 24, 2025Truist Financial$29.00$15.8782.73%16.28%
Nov 06, 2025Cantor Fitzgerald$42.00$14.75184.75%68.40%
Oct 29, 2025Etzer DaroutBarclays$23.00$14.2561.40%-7.78%
Oct 27, 2025Gregory RenzaRBC Capital$18.00$13.8330.15%-27.83%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 11, 2026BarclaysOverweightOverweighthold
Sep 01, 2026Raymond JamesStrong BuyStrong Buyhold
Aug 06, 2026Cantor FitzgeraldOverweightOverweighthold
Aug 06, 2026RBC CapitalOutperformOutperformhold
Dec 17, 2025BarclaysOverweightOverweighthold
Nov 06, 2025Cantor FitzgeraldOverweightOverweighthold
Oct 29, 2025BarclaysOverweightupgrade
Oct 27, 2025RBC CapitalOutperformOutperformhold
Aug 07, 2025WedbushOutperformOutperformhold
Apr 21, 2025William BlairOutperforminitialise

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.42$-0.93$-2.08$-3.58$-1.24---
Avg Forecast$0.24$-1.51$-1.90$-3.66$-3.10$-2.75$-1.58$-2.35
High Forecast$0.61$-0.31$0.70$-3.44$-2.79$0.92$0.04$-0.18
Low Forecast$0.05$-3.94$-4.56$-3.94$-3.69$-3.70$-2.47$-6.98
Surprise %491.67%-38.41%9.47%-2.19%-60.00%---

Revenue Forecast

$0 $120M $240M $360M $480M $600M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$275.11M$164.58M$174.62M$110.49M----
Avg Forecast$194.55M$164.55M$197.61M$61.23M$113.93M$163.51M$221.98M$236.72M
High Forecast$417.96M$368.50M$296.26M$68.72M$178.34M$163.63M$226.27M$594.59M
Low Forecast$76.47M$63.59M$106.64M$48.42M$48.25M$163.40M$217.69M$68.43M
Surprise %41.41%0.02%-11.64%80.44%----

Net Income Forecast

$-500M $-100M $300M $700M $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$82.63M$-55.18M$-133.13M$-232.62M$-91.92M---
Avg Forecast$1.05B$1.09B$-126.09M$-223.35M$-204.45M$-190.12M$-73.71M$-142.42M
High Forecast$1.27B$1.32B$-98.43M$-208.30M$-168.59M$55.53M$2.19M$-10.80M
Low Forecast$820.13M$851.78M$-153.74M$-238.40M$-223.23M$-224.00M$-149.61M$-422.34M
Surprise %-92.10%-105.08%5.59%4.15%-55.04%---

XNCR Forecast FAQ

Is Xencor stock a buy?

Xencor stock has a consensus rating of Buy, based on 28 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 24 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Xencor is a favorable investment for most analysts.

What is Xencor's price target?

Xencor's price target, set by 28 Wall Street analysts, averages $34.4 over the next 12 months. The price target range spans from $20 at the low end to $46 at the high end, suggesting a potential 37.93% change from the previous closing price of $24.94.

How does Xencor stock forecast compare to its benchmarks?

Xencor's stock forecast shows a 37.93% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Xencor over the past three months?

  • September 2026: 21.43% Strong Buy, 64.29% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 21.43% Strong Buy, 64.29% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 21.43% Strong Buy, 64.29% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is Xencor’s EPS forecast?

Xencor's average annual EPS forecast for its fiscal year ending in December 2026 is $-2.75, marking a 121.77% increase from the reported $-1.24 in 2025. Estimates for the following years are $-1.58 in 2027, and $-2.35 in 2028.

What is Xencor’s revenue forecast?

Xencor's average annual revenue forecast for its fiscal year ending in December 2026 is $163.51M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $221.98M, and $236.72M for 2028.

What is Xencor’s net income forecast?

Xencor's net income forecast for the fiscal year ending in December 2026 stands at $-190M, representing an 106.82% increase from the reported $-91.923M in 2025. Projections indicate $-73.713M in 2027, and $-142M in 2028.